Observational studyClinical rheumatology2026
Comparative effectiveness and predictors of SRI-4 and LLDAS attainment in active systemic lupus erythematosus: a real-world study of telitacicept versus belimumab.
Xinyi Shen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.